Could a vitamin a drug boost breast cancer treatment before surgery?
NCT ID NCT04113863
Summary
This study tested whether adding ATRA (a vitamin A-based drug) to standard hormone therapy (anastrozole) could better shrink tumors before surgery in postmenopausal women with early, hormone-sensitive breast cancer. Participants took the medications for four weeks before their scheduled surgery. The trial aimed to see if the combination caused more cancer cells to stop growing compared to the standard therapy alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASM FEMALE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ASST Papa Giovanni XXIII
Bergamo, 24127, Italy
-
Ospedale Santa Maria della Misericordia di Udine
Udine, UD, 33100, Italy
Conditions
Explore the condition pages connected to this study.